C A Watson Selected Research

Venous Thrombosis (Deep-Vein Thrombosis)

8/2009

Favorable therapeutic index of the direct factor Xa inhibitors, apixaban and rivaroxaban, compared with the thrombin inhibitor dabigatran in rabbits.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

C A Watson Research Topics

Disease

4	Thrombosis (Thrombus) 08/2009 - 01/2000
1	Fever (Fevers) 01/2017
1	Infections 10/2009
1	Venous Thrombosis (Deep-Vein Thrombosis) 08/2009
1	Carotid Artery Thrombosis 10/2000

Drug/Important Bio-Agent (IBA)

2	AntithrombinsIBA 08/2009 - 10/2000
2	apixabanIBA 08/2009 - 10/2008
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2008 - 10/2000
2	Factor Xa InhibitorsIBA 10/2008 - 10/2000
2	benzamidineIBA 10/2000 - 01/2000
2	tick anticoagulant peptideIBA 10/2000 - 01/2000
2	Heparin (Liquaemin)FDA LinkGeneric 10/2000 - 01/2000
1	BCG Vaccine FDA Link 10/2009
1	VaccinesIBA 10/2009
1	RivaroxabanIBA 08/2009
1	Dabigatran FDA Link 08/2009
1	Clopidogrel (Plavix)FDA Link 10/2008
1	AnticoagulantsIBA 10/2008
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 10/2000
1	acetylphenylalanyl-prolyl-boroarginineIBA 10/2000
1	(2S)- 2- (4- (((3S)- 1- acetimidoyl- 3- pyrrolidinyl)oxy)phenyl)- 3- (7- amidino- 2- naphtyl)propanoic acidIBA 01/2000
1	TrypsinIBA 01/2000
1	Fibrinolysin FDA Link 01/2000
1	Factor Xa (Coagulation Factor Xa)IBA 01/2000
1	Dalteparin (Dalteparin Sodium)FDA Link 01/2000
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2000
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2000
1	Thrombin FDA Link 01/2000

Therapy/Procedure

1	Induced Hyperthermia (Thermotherapy) 01/2017